COAs are property of Blueprint and are not to be used without Blueprint's consent.
Use during pregnancy or breastfeeding is not recommended due to insufficient study
Kirsner RS, Marston WA, Snyder RJ, Lee TD, Cargill DI, Zhang Y,
doi:10.2174/157015909787602788 Kappos L, Gold R, Miller DH, Macmanus DG, Havrdova E, Limmroth V, Polman CH, Schmierer K, Yousry TA, Yang M, Eraksoy M, Meluzinova E, Rektor I, Dawson KT, Sandrock AW, ONeil GN, BG-12 Phase IIb Study Investigators (2008) Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study